Inventor · disambiguated record
Martin A. Schwartz
Also filed as: SCHWARTZ MARTIN · SCHWARTZ MARTIN A · SCHWARTZ MARTIN ALAN
17 granted patents·3 pending applications·342 citations·filing 1975–2020
94Inventor score
Files withUNIV FLORIDA STATE5SCHWARTZ MARTIN A3UNIV COLORADO REGENTS3UNIV VIRGINIA3SCRIPPS RESEARCH INST2
Top patents by PatentIndex Score
20 records- 0197US4795813ASynthesis of derivatives of codeine and other 3-O-alkylmorphinesUNIV FLORIDA STATE·Filed 1986·Granted Jan 3, 1989·99 cites·32 claims
- 0296US4472253AProcess for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivativeUNIV FLORIDA STATE·Filed 1981·Granted Sep 18, 1984·59 cites·10 claims
- 0391US4003903AN-acyl-N-norsalutaridines and process for making themUNIV FLORIDA STATE·Filed 1975·Granted Jan 18, 1977·24 cites·19 claims
- 0488US9353121B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2012·Granted May 31, 2016·7 cites·6 claims
- 0578US5455262AMercaptosulfide metalloproteinase inhibitorsUNIV FLORIDA STATE·Filed 1993·Granted Oct 3, 1995·18 cites·41 claims
- 0677USRE34976EAnalog/digital voice storage cellular telephoneHELFERICH RICHARD J·Filed 1993·Granted Jun 20, 1995·58 cites·8 claims
- 0776US7838490B2Methods and compositions for inhibition of vascular permeabilityUNIV VIRGINIA·Filed 2006·Granted Nov 23, 2010·4 cites·13 claims
- 0876US7442681B2Method of inhibiting vascular permeabilityUNIV VIRGINIA·Filed 2005·Granted Oct 28, 2008·3 cites·19 claims
- 0969US8404866B2Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitorsSCHWARTZ MARTIN A·Filed 2009·Granted Mar 26, 2013·3 cites·29 claims
- 1068US5293113ATest instrument for the display of electric voltagesCH BEHA BMBH·Filed 1992·Granted Mar 8, 1994·38 cites·20 claims
- 1166US5470834ASulfoximine and suldodiimine matrix metalloproteinase inhibitorsUNIV FLORIDA STATE·Filed 1993·Granted Nov 28, 1995·10 cites·43 claims
- 1264US11964985B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2020·Granted Apr 23, 2024·0 cites·13 claims
- 1359US10689392B2Anti-cancer compounds targeting ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2016·Granted Jun 23, 2020·0 cites·9 claims
- 1454US4647671ACleavable cross-linking reagentSCHWARTZ MARTIN A·Filed 1985·Granted Mar 3, 1987·4 cites·8 claims
- 1553US7125849B2Peptide-based angiogenesis inhibitors and methods of use thereofSCRIPPS RESEARCH INST·Filed 2003·Granted Oct 24, 2006·0 cites·12 claims
- 1653US6013495AMethods of use for integrin B1C cell growth inhibitorSCRIPPS RESEARCH INST·Filed 1997·Granted Jan 11, 2000·6 cites·4 claims
- 1746US2016067314A1Compositions and methods for inhibiting chemoresistance in cancer and improving response to therapySCHWARTZ MARTIN A·Filed 2014·Application pending·0 cites
- 1843US4487838ARadio-labelled cross-linking reagentsMASSACHUSETTS INST TECHNOLOGY·Filed 1982·Granted Dec 11, 1984·9 cites·11 claims
- 1940US2009022712A1Compositions and Methods for Inhibiting Leukocyte FunctionUNIV VIRGINIA·Filed 2007·Application pending·0 cites
- 2029US2002102240A1Methods for use for integrin b1c cell growth inhibitorFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin A. Schwartz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →